Applied Therapeutics Stock Technical Analysis

APLT Stock  USD 0.10  0.00  0.00%   
As of the 11th of February 2026, Applied Therapeutics shows the Risk Adjusted Performance of (0.15), standard deviation of 12.45, and Mean Deviation of 7.02. Applied Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Applied Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Applied, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AppliedApplied Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Applied Therapeutics Analyst Consensus

Target PriceConsensus# of Analysts
0.25Buy4Odds
Applied Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Applied analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Applied stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Applied Therapeutics, talking to its executives and customers, or listening to Applied conference calls.
Applied Analyst Advice Details
Is there potential for Biotechnology market expansion? Will Applied introduce new products? Factors like these will boost the valuation of Applied Therapeutics. If investors know Applied will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Applied Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.10)
Revenue Per Share
0.007
Quarterly Revenue Growth
7.197
Return On Assets
(0.88)
Return On Equity
(6.80)
The market value of Applied Therapeutics is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Applied Therapeutics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Applied Therapeutics' market value can be influenced by many factors that don't directly affect Applied Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Applied Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Applied Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Applied Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Applied Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Applied Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Applied Therapeutics.
0.00
11/13/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/11/2026
0.00
If you would invest  0.00  in Applied Therapeutics on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Applied Therapeutics or generate 0.0% return on investment in Applied Therapeutics over 90 days. Applied Therapeutics is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular... More

Applied Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Applied Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Applied Therapeutics upside and downside potential and time the market with a certain degree of confidence.

Applied Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Applied Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Applied Therapeutics' standard deviation. In reality, there are many statistical measures that can use Applied Therapeutics historical prices to predict the future Applied Therapeutics' volatility.
Hype
Prediction
LowEstimatedHigh
0.010.1012.91
Details
Intrinsic
Valuation
LowRealHigh
0.010.1412.95
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.12-0.12-0.11
Details

Applied Therapeutics February 11, 2026 Technical Indicators

Applied Therapeutics Backtested Returns

Applied Therapeutics secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14 % return per unit of risk over the last 3 months. Applied Therapeutics exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Applied Therapeutics' Standard Deviation of 12.45, mean deviation of 7.02, and Risk Adjusted Performance of (0.15) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.83, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Applied Therapeutics are expected to decrease at a much lower rate. During the bear market, Applied Therapeutics is likely to outperform the market. At this point, Applied Therapeutics has a negative expected return of -1.24%. Please make sure to confirm Applied Therapeutics' variance, potential upside, as well as the relationship between the Potential Upside and day typical price , to decide if Applied Therapeutics performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.38  

Below average predictability

Applied Therapeutics has below average predictability. Overlapping area represents the amount of predictability between Applied Therapeutics time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Applied Therapeutics price movement. The serial correlation of 0.38 indicates that just about 38.0% of current Applied Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient0.38
Spearman Rank Test-0.03
Residual Average0.0
Price Variance0.0
Applied Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Applied Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Applied Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Applied Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Applied Therapeutics across different markets.

About Applied Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Applied Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Applied Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Applied Therapeutics price pattern first instead of the macroeconomic environment surrounding Applied Therapeutics. By analyzing Applied Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Applied Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Applied Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2025 2026 (projected)
Payables Turnover9.98.41
Days Of Inventory On Hand20.0117.78

Applied Therapeutics February 11, 2026 Technical Indicators

Most technical analysis of Applied help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Applied from various momentum indicators to cycle indicators. When you analyze Applied charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Applied Therapeutics February 11, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Applied stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.